Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May;24(9):5021-5027.
doi: 10.1111/jcmm.15122. Epub 2020 Apr 3.

Hsa_circ_0079662 induces the resistance mechanism of the chemotherapy drug oxaliplatin through the TNF-α pathway in human colon cancer

Affiliations

Hsa_circ_0079662 induces the resistance mechanism of the chemotherapy drug oxaliplatin through the TNF-α pathway in human colon cancer

Mingfen Lai et al. J Cell Mol Med. 2020 May.

Abstract

The aim of the study was to research the biological functions of circRNA (hsa_circ_0079662) and its underlying mechanism in colorectal cancer. Drug-resistant cell lines (HT29-LOHP, HCT116-LOHP, HCT8-LOHP) were separately dealt with oxaliplatin concentration gradient (0.1-10 μmol/L). Real-time PCR, Western blotting, dual-luciferase assay, miRNA pull-down assay, coimmunoprecipitation and ELASA were performed to explore the mechanism of chemotherapy drug oxaliplatin resistance in CRC. The results showed that the expression of hsa_circ_0079662 was increased in drug-resistant cell lines by RT-PCR. The expression of HOXA9, TRIP6, Vcam-1, VEGFC, MMP3, MMP9 and MMP14 was higher by Western blotting. Interaction between HOXA9 and TRIP6 in CO-IP detection. Additionally, the cytokines TNF-α, IL-1 and IL-6 were also found. In conclusion, hsa_circ_0079662, as a ceRNA binding with hsa-mir-324-5p, can regulate target gene HOXA9 and induced the mechanism of chemotherapy drug oxaliplatin resistance in CRC through the TNF-α pathway in human colon cancer.

Keywords: HOXA9; Hsa_circ_0079662; TNF-α pathway; ceRNA; colorectal cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Hsa_circ_0079662 is up‐regulated in drug‐resistant CRC cell lines
Figure 2
Figure 2
Hsa_circ_0079662 promotes growth of drug‐resistant CRC cell lines
Figure 3
Figure 3
Hsa_circ_0079662 in hsa‐mir‐324‐5p treated cells, significantly reversed the growth‐inhibitory role. ****P < .001
Figure 4
Figure 4
Hsa‐mir‐324‐5p treatment decreased cell growth of cells. *P < .05
Figure 5
Figure 5
The expression of cytokines TNF‐α, IL‐1 and IL‐6 was increased in drug‐resistant CRC. *P < .05

Similar articles

Cited by

References

    1. Gong Y, Dong R, Gao X, et al. Neohesperidin prevents colorectal tumorigenesis by altering the gut microbiota. Pharmacol Res. 2019;148:104460. - PubMed
    1. Vinson KE, George DC, Fender AW, Bertrand FE, Sigounas G. The Notch pathway in colorectal cancer. Int J Cancer. 2016;138:1835‐1842. - PubMed
    1. Yashiro M. Molecular alterations of colorectal cancer with inflammatory bowel disease. Dig Dis Sci. 2015;60:2251‐2263. - PubMed
    1. Zheng Y, Nie P, Xu S. Long noncoding RNA CASC21 exerts an oncogenic role in colorectal cancer through regulating miR‐7‐5p/YAP1 axis. Biomed Pharmacother. 2020;121:109628. - PubMed
    1. Silvestro M, Hadi T, Cayne NS, et al. AAA 25. Cell‐specific profiling of transcriptional landscape in human abdominal aortic aneurysm by single‐cell RNA sequencing. J Vasc Surg. 2019;70(5):e142‐e143.

MeSH terms